XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details Narrative) (USD $)
3 Months Ended 1 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Feb. 29, 2012
Management - Stock Options
Feb. 29, 2012
Convertible Promissory Note
Nov. 30, 2010
Warrant Grants - Transition Partners, Limited
Jun. 30, 2011
Warrant Grants - AVIDBank
Jul. 31, 2011
Warrant Grants - Breakwater Structured Growth Opportunity Fund, L.P.
Jan. 31, 2013
Warrant Grants - Microcap Headlines, Inc.
Sep. 30, 2012
Option Grant - R. Jerry Falkner
Sep. 30, 2012
Option Grant - Company Employees
Nov. 30, 2012
Option Grant - Consultants
Stock options issued     823,757           125,000 54,479 100,000
Stock options exercise price     $ 0.573           $ 2.25 $ 2.25 $ 2.50
Stock issued upon conversion of notes payable       329,502              
Stock warrants granted         123,563 33,401 420,549 100,000      
Stock warrants granted exercise price         0.57     2.25      
Current stock value $ 0.01 $ 0.01       $ 2.85 $ 1.88 $ 2.28 $ 2.06    
Stock options and warrants granted expiration date         Jul. 31, 2015 Jun. 17, 2016 Jun. 15, 2016 Jan. 01, 2018 Sep. 05, 2017 Sep. 27, 2022 Nov. 30, 2022
Stock options and warrants vesting period           Fully vested   One-fourth increments. First increment was granted and fully vested on January 1, 2013 and the second was granted and fully vested on April 1, 2013. Conditional vesting schedule, in one-fourth increments. The first installment vested September 6, 2012, the second vested on November 30, 2012, the third vested on February 28, 2013 and the fourth installment will vest 180 day following the publication of this report. Three year vesting schedules of 1/3 each year through September 2015. Three year vesting schedule in one-third increments. The first vesting period begins on November 30, 2013.
Discount assumption           24.00% 50.00% 24.00% 24.00%    
Risk free interest rate, minimum           0.36% 0.36% 0.36% 0.36%    
Risk free interest rate, maximum           0.77% 0.77% 0.77% 0.77%    
Weighted average expected terms           From 3.25 to 4.75 years From 3.25 to 4.75 years From 3.25 to 4.75 years From 3.25 to 4.75 years    
Expected volatility           45.95% 45.95% 45.95% 45.95%    
Valuation expenses recognized $ 50,777                    
Stock option valuation expense allocated to other income expense $ 178,844